FDA Reviewing Chantix Postmarketing Data On Suicide, Erratic Behavior

Early communication by the agency follows one case of erratic behavior leading to the death of a patient using the smoking cessation drug.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet